PENTEC
LIVE

Serial Number

97880977

Owner

Pentec Health, Inc.

Attorney

David P. Fitzgibbon

First Use Date

Jun 1, 2023

Filing Date

Apr 10, 2023

Add to watchlist:

No watchlists yet
View on USPTO

PENTEC Trademark

Serial Number: 97880977 • Registration: 8145879

PENTEC is a trademark filed by Pentec Health, Inc. on April 10, 2023. The trademark is classified under Class 5 (Pharmaceuticals), Class 36 (Insurance & Financial), Class 41 (Education & Entertainment), Class 44 (Medical Services), Class 35 (Advertising & Business). The application is currently registered and active.

Owner Contact Info

Pentec Health, Inc. (26 trademarks)

Suite A
Boothwyn, PA 19061

Entity Type: 03

Trademark Details

Filing Date

April 10, 2023

Registration Date

February 17, 2026

First Use Anywhere

June 1, 2023

First Use in Commerce

June 1, 2023

Published for Opposition

May 14, 2024

Goods & Services

Pharmaceutical advice for renal clinics, pain and spasticity management physician practices, nephrologists, dietitians, and oncologists; specialized closed-door, sterile, compounding pharmacy services, namely, pharmaceutical compounding services for renal patients, wound care patients, pain and spasticity patients, patients with implanted intrathecal pumps, patients with implanted hepatic artery pumps, patients with diabetes, patients with clinical nutrition deficiencies, and cancer patients; healthcare, namely, providing specialty infusion therapy for renal patients, wound care patients, patients with implanted intrathecal pumps, patients with implanted hepatic artery pumps, pain and spasticity patients, patients with diabetes, patients with clinical nutrition deficiencies, and cancer patients; providing healthcare services featuring supplemental oral nutrition therapy, nutrition therapy, nutrition counseling, and medical food therapy programs to patients and healthcare providers; Health care services for treating patients with clinical nutrition deficiencies by providing medical food formulated for administration under medical supervision

Pharmaceutical services, namely, processing prescription drug orders in closed-door, sterile, compounding pharmacies; specialized closed-door, sterile, compounding pharmacy services, namely, processing prescription drug orders for renal patients, wound care patients, pain and spasticity patients, patients with implanted intrathecal pumps, patients with implanted hepatic artery pumps, patients with diabetes, patients with clinical nutrition deficiencies, and cancer patients; consulting services, namely, providing consumer information about health care plans

Providing information regarding health care claim insurance, claim information, and payment options to health care providers, insurers, and consumers

Oral nutritional supplements; dietetic foods adapted for medical use; parenteral nutrition delivered intravenously to treat patients with clinical nutritional deficiencies; enteral nutrition formulas used to treat individuals with inborn errors of metabolism and metabolic conditions; vials containing compounded sterile preparations in the nature of sterile pharmaceutical preparations for renal patients, wound care patients, pain and spasticity patients, patients with implanted intrathecal pumps, patients with implanted hepatic artery pumps, patients with diabetes, patients with clinical nutrition deficiencies, and cancer patients; syringes containing compounded sterile preparations in the nature of sterile pharmaceutical preparations for renal patients, wound care patients, pain and spasticity patients, patients with implanted intrathecal pumps, patients with implanted hepatic artery pumps, patients with diabetes, patients with clinical nutrition deficiencies, and cancer patients

Educational services, namely, providing educational seminars to industry healthcare professionals in the field of care of patients suffering from chronic kidney disease (CKD), end stage renal disease (ESRD), diabetes, intractable pain, and spasticity conditions, gastrointestinal disorders, clinical nutrition deficiencies related to chronic diseases, and cancer

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Feb 17, 2026 NRCC
REGISTERED-PRINCIPAL REGISTER
Feb 17, 2026 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Jan 28, 2026 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Jan 28, 2026 CNPR
STATEMENT OF USE PROCESSING COMPLETE
Jan 8, 2026 SUPC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Jan 8, 2026 AITU
USE AMENDMENT FILED
Jul 3, 2025 IUAF
TEAS STATEMENT OF USE RECEIVED
Jul 3, 2025 EISU
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 3, 2025 EXRA
SOU EXTENSION 1 GRANTED
Jan 7, 2025 EX1G
SOU EXTENSION 1 FILED
Jan 7, 2025 EXT1
SOU TEAS EXTENSION RECEIVED
Jan 7, 2025 EEXT
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Jan 6, 2025 EWAF
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jan 6, 2025 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jan 6, 2025 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jan 6, 2025 REAP
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jul 9, 2024 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 14, 2024 NPUB
PUBLISHED FOR OPPOSITION
May 14, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Apr 24, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 9, 2024 CNSA
EXAMINER'S AMENDMENT ENTERED
Apr 9, 2024 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Apr 9, 2024 GNEN
EXAMINERS AMENDMENT E-MAILED
Apr 9, 2024 GNEA
EXAMINERS AMENDMENT -WRITTEN
Apr 9, 2024 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 6, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 4, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Apr 4, 2024 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jan 5, 2024 GNRN
NON-FINAL ACTION E-MAILED
Jan 5, 2024 GNRT
NON-FINAL ACTION WRITTEN
Jan 5, 2024 CNRT
ASSIGNED TO EXAMINER
Jan 5, 2024 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 4, 2023 NWOS
NEW APPLICATION ENTERED
Apr 13, 2023 NWAP